1. A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer. Issue 9 (22nd December 2020) Authors: Cecchini, Michael; Kortmansky, Jeremy S.; Cui, Can; Wei, Wei; Thumar, Jaykumar Ranchobdhai; Uboha, Nataliya V.; Hafez, Navid; Lacy, Jill; Fischbach, Neal A.; Sabbath, Kert D.; Gomez, Christina M.; Sporn, Jonathan Reed; Stein, Stacey; Hochster, Howard S. Journal: Cancer Issue: Volume 127:Issue 9(2021) Page Start: 1417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Issue 7 (August 2020) Authors: Cecchini, Michael; Miccio, Joseph A.; Pahade, Jay; Lacy, Jill; Salem, Ronald R.; Johnson, Skyler B.; Blakaj, Adriana; Stein, Stacey; Kortmansky, Jeremy S.; Johung, Kimberly L. Journal: Pancreas Issue: Volume 49:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Issue 6 (June 2020) Authors: Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn, Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee, Kyung-Hun Journal: Lancet oncology Issue: Volume 21:Issue 6(2020) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity. Issue 1 (December 2015) Authors: Zhang, Yue; Hochster, Howard; Stein, Stacey; Lacy, Jill Journal: Experimental hematology & oncology Issue: Volume 4:Issue 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis. (March 2021) Authors: Miccio, Joseph A.; Talcott, Wesley J.; Patel, Timil; Park, Henry S.; Cecchini, Michael; Salem, Ronald R.; Khan, Sajid A.; Stein, Stacey; Kortmansky, Jeremy S.; Lacy, Jill; Narang, Amol; Herman, Joseph; Jabbour, Salma K.; Hallemeier, Christopher L.; Johung, Kimberly; Jethwa, Krishan R. Journal: Clinical and translational radiation oncology Issue: Volume 27(2021) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation. Issue 10 (October 2021) Authors: Eng, Cathy; Chen, Emerson Y.; Rogers, Jane; Lewis, Mark; Strosberg, Jonathan; Thota, Ramya; Krishnamurthi, Smitha; Oberstein, Paul; Govindarajan, Rang; Buchschacher, Gary; Patel, Sandip; Sohal, Davendra; Al-Toubah, Taymeyah; Philip, Philip; Dasari, Arvind; Kennecke, Hagan; Stein, Stacey Journal: JCO oncology practice Issue: Volume 17:Issue 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer. (21st November 2022) Authors: Mokhtech, Meriem; Miccio, Joseph A.; Johung, Kimberly; Cecchini, Michael; Stein, Stacey; Narang, Amol K.; Herman, Joseph M.; Kunstman, John; Haddock, Michael G.; Anker, Christopher J.; Jabbour, Salma; Hallemeier, Christopher L.; Jethwa, Krishan R. Journal: American journal of clinical oncology Issue: Volume 45:Number 11(2022) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗